Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.97 NOK | +3.64% | +14.51% | -93.51% |
Sales 2024 * | 636M 58.8M | Sales 2025 * | 404M 37.38M | Capitalization | 274M 25.37M |
---|---|---|---|---|---|
Net income 2024 * | 361M 33.39M | Net income 2025 * | 267M 24.7M | EV / Sales 2024 * | -0.83 x |
Net cash position 2024 * | 803M 74.25M | Net cash position 2025 * | 1.08B 99.99M | EV / Sales 2025 * | -2 x |
P/E ratio 2024 * |
0.91
x | P/E ratio 2025 * |
1.01
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.97% |
Latest transcript on Ultimovacs ASA
1 day | +3.64% | ||
1 week | +14.51% | ||
Current month | -94.08% | ||
1 month | -94.09% | ||
3 months | -93.19% | ||
6 months | -91.05% | ||
Current year | -93.51% |
Managers | Title | Age | Since |
---|---|---|---|
Carlos de Sousa
CEO | Chief Executive Officer | 66 | 20-05-31 |
Director of Finance/CFO | 57 | - | |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leiv Askvig
BRD | Director/Board Member | 67 | 14-12-31 |
Jónas Einarsson
CHM | Chairman | 67 | 11-01-25 |
Henrik Schüssler
BRD | Director/Board Member | 61 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 7.97 | +3.64% | 609,207 |
24-03-26 | 7.69 | -2.66% | 507,771 |
24-03-25 | 7.9 | +1.28% | 1,367,177 |
24-03-22 | 7.8 | +23.22% | 2,814,933 |
24-03-21 | 6.33 | -9.05% | 1,082,938 |
Real-time Oslo Bors, March 27, 2024 at 09:20 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-93.51% | 25.4M | |
+9.22% | 45.97B | |
+52.73% | 43.93B | |
+9.50% | 42.34B | |
-8.59% | 28.27B | |
+17.86% | 27.18B | |
-20.73% | 19.44B | |
+13.95% | 13.83B | |
+31.61% | 12.4B | |
+9.50% | 11.45B |